Hepatitis C Virus-Induced Monocyte Differentiation Into Polarized M2 Macrophages Promotes Stellate Cell Activation via TGF-β

Cellular and Molecular Gastroenterology and Hepatology

Volumn 2, Issue 3, 2016, Pages 302-316.e8

  Saha, Banishree ^a   Kodys, Karen ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Biomarkers; CD206; Collagen; Fibrocytes

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; STELLATE CELL;

EID: 84961219431     PISSN: None     EISSN: 2352345X     Source Type: Journal    
DOI: 10.1016/j.jcmgh.2015.12.005     Document Type: Article

References (54)

1. Mohd Hanafiah K., Groeger J., Flaxman A.D., et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57:1333-1342.
2. Messina J.P., Humphreys I., Flaxman A., et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015, 61:77-87.
3. Webster D.P., Klenerman P., Dusheiko G.M. Hepatitis C. Lancet 2015, 385:1124-1135.
4. Rein D.B., Wittenborn J.S., Smith B.D., et al. The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus. Clin Infect Dis 2015, 61:157-168.
5. Bekeredjian-Ding I., Roth S.I., Gilles S., et al. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J Immunol 2006, 176:7438-7446.
6. Medzhitov R., Janeway C.A. Decoding the patterns of self and nonself by the innate immune system. Science 2002, 296:298-300.
7. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 2010, 22:41-47.
8. Liu B.S., Groothuismink Z.M., Janssen H.L., et al. Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections. J Leukoc Biol 2011, 89:981-988.
9. Cros J., Cagnard N., Woollard K., et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33:375-386.
10. Saha B., Bala S., Hosseini N., et al. Krüppel-like factor 4 is a transcriptional regulator of M1/M2 macrophage polarization in alcoholic liver disease. J Leukoc Biol 2015, 97:963-973.
11. Cassol E., Cassetta L., Alfano M., et al. Macrophage polarization and HIV-1 infection. J Leukoc Biol 2010, 87:599-608.
12. Lawn S.D., Butera S.T., Folks T.M. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001, 14:753-777. table of contents.
13. Liu B.S., Janssen H.L., Boonstra A. Type I and III interferons enhance IL-10R expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12. Eur J Immunol 2012, 42:2431-2440.
14. Liaskou E., Zimmermann H.W., Li K.K., et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology 2013, 57:385-398.
15. Dolganiuc A., Norkina O., Kodys K., et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 2007, 133:1627-1636.
16. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009, 27:669-692.
17. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011, 11:762-774.
18. Klein I., Cornejo J.C., Polakos N.K., et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 2007, 110:4077-4085.
19. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
20. Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014, 6:13.
21. Rey-Giraud F., Hafner M., Ries C.H. In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS One 2012, 7:e42656.
22. Lolmede K., Campana L., Vezzoli M., et al. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol 2009, 85:779-787.
23. Schuppan D., Krebs A., Bauer M., et al. Hepatitis C and liver fibrosis. Cell Death Differ 2003, 10(Suppl 1):S59-S67.
24. Schuppan D., Schattenberg J.M. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol 2013, 28(Suppl 1):68-76.
25. Kolb M., Margetts P.J., Anthony D.C., et al. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001, 107:1529-1536.
26. Oikonomou N., Harokopos V., Zalevsky J., et al. Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS One 2006, 1:e108.
27. Shirasaki T., Honda M., Shimakami T., et al. Impaired IFN signaling in chronic hepatitis C patients with advanced fibrosis via the TGF-beta signaling pathway. Hepatology 2014, 60:1519-1530.
28. Li S., Vriend L.E., Nasser I.A., et al. Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis. Hepatology 2012, 56:2094-2105.
29. Serti E., Werner J.M., Chattergoon M., et al. Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication. Gastroenterology 2014, 147:209-220.e3.
30. Zhang S., Kodys K., Li K., et al. Human type 2 myeloid dendritic cells produce interferon-lambda and amplify interferon-alpha in response to hepatitis C virus infection. Gastroenterology 2013, 144:414-425.e7.
31. Castilho-Fernandes A., de Almeida D.C., Fontes A.M., et al. Human hepatic stellate cell line (LX-2) exhibits characteristics of bone marrow-derived mesenchymal stem cells. Exp Mol Pathol 2011, 91:664-672.
32. Hou W., Bukong T.N., Kodys K., et al. Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells. Alcohol Clin Exp Res 2013, 37:599-608.
33. Dolganiuc A., Oak S., Kodys K., et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004, 127:1513-1524.
34. Chattergoon M.A., Latanich R., Quinn J., et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog 2014, 10:e1004082.
35. Heydtmann M. Macrophages in hepatitis B and hepatitis C virus infections. J Virol 2009, 83:2796-2802.
36. Verreck F.A., de Boer T., Langenberg D.M., et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 2004, 101:4560-4565.
37. Martinez F.O., Gordon S., Locati M., et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006, 177:7303-7311.
38. Luo D.D., Fielding C., Phillips A., et al. Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling. Nephrol Dial Transplant 2009, 24:2655-2665.
39. Granowitz E.V., Clark B.D., Vannier E., et al. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 1992, 79:2356-2363.
40. Wakita T., Pietschmann T., Kato T., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005, 11:791-796.
41. Pilling D., Fan T., Huang D., et al. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009, 4:e7475.
42. Reilkoff R.A., Bucala R., Herzog E.L. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 2011, 11:427-435.
43. Wree A., Eguchi A., McGeough M.D., et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 2014, 59:898-910.
44. Barth H., Rybczynska J., Patient R., et al. Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees. Hepatology 2011, 54:1135-1148.
45. Boltjes A., Movita D., Boonstra A., et al. The role of Kupffer cells in hepatitis B and hepatitis C virus infections. J Hepatol 2014, 61:660-671.
46. Hosomura N., Kono H., Tsuchiya M., et al. HCV-related proteins activate Kupffer cells isolated from human liver tissues. Dig Dis Sci 2011, 56:1057-1064.
47. Sica A., Invernizzi P., Mantovani A. Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology 2014, 59:2034-2042.
48. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11:723-737.
49. Yang L., Scott P.G., Giuffre J., et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002, 82:1183-1192.
50. Mathai S.K., Gulati M., Peng X., et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 2010, 90:812-823.
51. Tourkina E., Bonner M., Oates J., et al. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair 2011, 4:15.
52. Niedermeier M., Reich B., Rodriguez Gomez M., et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci U S A 2009, 106:17892-17897.
53. Kisseleva T., Uchinami H., Feirt N., et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006, 45:429-438.
54. Nunnari G., Vancheri C., Gilli E., et al. Circulating fibrocytes as a marker of liver fibrosis in chronic hepatitis C. Front Biosci (Elite Ed) 2010, 2:1241-1245.